imvamune

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2015
02420062015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Concern over the release of variola virus as an agent of bioterrorism remains high and a rapid vaccination regimen is desirable… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2015
2015
INTRODUCTION Previous research shows immune response to vaccination differs by sex but this has not been explored for IMVAMUNE, a… (More)
Is this relevant?
2013
2013
To support the licensure of a new and safer vaccine to protect people against smallpox, a monkeypox model of infection in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2013
2013
BACKGROUND Modified vaccinia Ankara (MVA-BN, IMVAMUNE) is emerging as a primary immunogen and as a delivery system to treat or… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
Infection of rabbits with aerosolized rabbitpox virus (RPXV) produces a disease similar to monkeypox and smallpox in humans and… (More)
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Review
2009
Review
2009
Smallpox vaccines based on replicating vaccinia virus are known to elicit rare yet serious adverse events, particularly in human… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
BACKGROUND Symptomatic myopericarditis has been described after smallpox vaccination using replication-competent vaccinia strains… (More)
Is this relevant?
2008
2008
Bavarian Nordic is developing IMVAMUNE, which is based on a live attenuated modified vaccinia Ankara virus, for the potential… (More)
Is this relevant?
2007
2007
Smallpox vaccination with replication deficient vaccinia strains such as Modified Vaccinia Ankara (MVA) may induce protective… (More)
Is this relevant?
2006
2006
A Phase I trial was performed to investigate the safety and immunogenicity of the third generation smallpox vaccine MVA-BN… (More)
Is this relevant?